Cargando…

Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics

Post‐transplant diabetes mellitus (PTDM) shows a relationship with risk factors including obesity and tacrolimus‐based immunosuppression, which decreases pancreatic insulin secretion. Several of the sodium–glucose‐linked transporter 2 inhibitors (SGLT2is) and glucagon‐like peptide 1 receptor agonist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hecking, Manfred, Sharif, Adnan, Eller, Kathrin, Jenssen, Trond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839745/ https://www.ncbi.nlm.nih.gov/pubmed/33135259 http://dx.doi.org/10.1111/tri.13783

Ejemplares similares

Comment on: Chakkera et al. Can New-Onset Diabetes After Kidney Transplant Be Prevented? Diabetes Care 2013;36:1406–1412
por: Hecking, Manfred, et al.
Publicado: (2013)

Cardiovascular events associate with diabetes status rather than with early basal insulin treatment for the prevention of post-transplantation diabetes mellitus
por: Topitz, David, et al.
Publicado: (2019)

Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2‐year diagnostic accuracy study of participants from a randomized controlled trial
por: Kurnikowski, Amelie, et al.
Publicado: (2022)

Influence of Early Postoperative Basal Insulin Treatment and Post-Transplant Diabetes Mellitus Risk on Health-Related Quality of Life in Kidney Transplant Recipients—An Analysis of Data From a Randomized Controlled Trial
por: Odler, Balazs, et al.
Publicado: (2023)

Managing the “Sword of Damocles” of Immunosuppression: Prevention, Early Diagnosis, and Treatment of Infectious Diseases in Kidney Transplantation
por: Cacciola, Roberto, et al.
Publicado: (2023)

Comment on: Chakkera et al. Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation. Diabetes Care 2011;34:2141–2145
por: Valderhaug, Tone Gretland, et al.
Publicado: (2012)

Early post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression
por: Agrawal, Amogh, et al.
Publicado: (2023)

Management of post cardiac transplantation immunosuppression and COVID-19: A case report
por: Melhaoui, Imane, et al.
Publicado: (2021)

Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression
por: Baron, Pedro W., et al.
Publicado: (2017)

Chronic kidney disease in patients with diabetes mellitus
por: Nordheim, Espen, et al.
Publicado: (2021)

Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation
por: Anggelia, Madonna Rica, et al.
Publicado: (2022)

Diabetes: cost of illness in Norway
por: Solli, Oddvar, et al.
Publicado: (2010)

Induction immunosuppression and post-transplant diabetes mellitus: a propensity-matched cohort study
por: Gupta, Suruchi K., et al.
Publicado: (2023)

The association of early post-transplant glucose levels with long-term mortality
por: Valderhaug, T. G., et al.
Publicado: (2011)

Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR
por: Arshad, Adam, et al.
Publicado: (2021)

Glucose Metabolism After Renal Transplantation
por: Hecking, Manfred, et al.
Publicado: (2013)

Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: Systematic review and meta-analysis
por: Kotha, Sreelakshmi, et al.
Publicado: (2021)

Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Based Immunosuppression
por: Yousif, Elamein, et al.
Publicado: (2022)

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation
por: Lim, Eu Jin, et al.
Publicado: (2015)

Management and prevention of post-transplant malignancies in kidney transplant recipients
por: Stallone, Giovanni, et al.
Publicado: (2015)

Post-Renal Transplant Diabetes Mellitus in Korean Subjects: Superimposition of Transplant-Related Immunosuppressant Factors on Genetic and Type 2 Diabetic Risk Factors
por: Lee, Hyun Chul
Publicado: (2012)

Impact of Immunosuppression on the Metagenomic Composition of the Intestinal Microbiome: a Systems Biology Approach to Post-Transplant Diabetes
por: Bhat, M., et al.
Publicado: (2017)

Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?
por: Faucher, Quentin, et al.
Publicado: (2022)

Acute diabetic foot in post kidney transplantation patients receiving chronic immunosuppression—clinical presentation and outcomes
por: Gorin, Kobi, et al.
Publicado: (2022)

Immunosuppressant Management in Renal Transplant Patients with COVID-19
por: Ahmadian, Elham, et al.
Publicado: (2021)

Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics
por: Montero, Nuria, et al.
Publicado: (2021)

The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation
por: Albekairy, Abdulkareem M., et al.
Publicado: (2018)

Evidence of Immunosuppressive and Th2 Immune Polarizing Effects of Antidiabetic Momordica charantia Fruit Juice
por: Fachinan, Rufine, et al.
Publicado: (2017)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
por: Toapanta, Néstor, et al.
Publicado: (2022)

Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation
por: Gandolfini, Ilaria, et al.
Publicado: (2022)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Learned immunosuppressive placebo responses in renal transplant patients
por: Kirchhof, Julia, et al.
Publicado: (2018)

Dysregulation of Th17 Cells during the Early Post-Transplant Period in Patients under Calcineurin Inhibitor Based Immunosuppression
por: Chung, Byung Ha, et al.
Publicado: (2012)

Thromboinflammatory response is increased in pancreas transplant alone versus simultaneous pancreas-kidney transplantation and early pancreas graft thrombosis is associated with complement activation
por: Rydenfelt, Kristina, et al.
Publicado: (2023)

Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
por: Ussif, Amin M., et al.
Publicado: (2019)

Treatment of post-transplant recurrent FSGS in children using plasmapheresis and augmentation of immunosuppression
por: Restrepo, Jaime M., et al.
Publicado: (2022)

Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Inflammation in the early phase after kidney transplantation is associated with increased long‐term all‐cause mortality
por: Heldal, Torbjørn Fossum, et al.
Publicado: (2022)

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections
por: Faura, Júlia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fqc845f2ro08mpef4716a8vgnn